Centocor, Inc.
113
1
1
99
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
10.6%
12 terminated/withdrawn out of 113 trials
89.2%
+2.7% vs industry average
42%
47 trials in Phase 3/4
51%
50 of 99 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (113)
A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)
Role: collaborator
German Spondyloarthritis Inception Cohort
Role: collaborator
Infliximab, Regulatory T Cells, IL2 and Crohn's Disease
Role: collaborator
Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
Role: collaborator
European Safety Registry in Ulcerative Colitis (P04808)
Role: collaborator
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
Role: collaborator
Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab
Role: collaborator
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Role: lead
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Role: lead
Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
Role: collaborator
A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis
Role: lead
A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)
Role: collaborator
Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)
Role: collaborator
Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)
Role: collaborator
Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
Role: collaborator
Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis
Role: collaborator
Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
Role: collaborator
Beryllium Infliximab Study: Clinical Interventional Trial
Role: collaborator
Seronegative Oligoarthritis of the Knee Study (SOKS)
Role: collaborator
A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Role: lead